glp-1 telehealth crackdown news today FDA takes aim at companies for promoting unofficial weight loss drug dupes Telehealth booms on surging GLP-1

Liver Fat & Inflammation In a MASLD study, Retatrutide achieved over 80% liver-fat reduction and normalised liver enzymes in most participants

Amid this epidemic, a transformative class of medications GLP-1 receptor agonists (GLP- 1RAs) has revolutionized weight loss and chronic disease management

As payers increasingly prioritize cost-effective, sustainable solutions, the time is right for digital health innovators to seize this once-in-a-lifetime opportunity and make a meaningful impact on global health

On the more positive side, this user experienced a reduction in appetite and improved energy after starting the supplement